📚 ESC 2025 Coverage: AQUATIC Trial challenges aspirin on top of anticoagulation in chronic coronary syndrome.
Do these patients really need dual-pathway inhibition, or does anticoagulation alone rule the game?
اولین نفر کامنت بزار
تمامی حقوق این وبسایت متعلق به شنوتو است